Gene therapy cure for sickle cell awaits advisory approval
HQ Team October 28, 2023: Advisers to the Food and Drug Administration (FDA) are set to review a gene therapy for sickle cell.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team October 28, 2023: Advisers to the Food and Drug Administration (FDA) are set to review a gene therapy for sickle cell.
HQ Team October 28, 2023: A recent study conducted by a team of researchers from Denmark, the Netherlands, and the United Kingdom challenges.
HQ Team October 27, 2023: Brazilian scientists have developed an innovative vaccine known as “Calixcoca” for cocaine addiction, a pervasive problem in the.
HQ Team October 27, 2023: Millions of individuals managing diabetes rely on metformin to regulate their blood sugar levels. Recent research highlights the.
HQ Team October 26, 2023: While athlete’s foot and yeast infections are well-known, a new threat is emerging from invasive fungal infections, which.
HQ Team October 26, 2023: Scientists at the University of Notre Dame have developed an innovative device that can decode the messages exchanged.
HQ Team October 21, 2023: The FDA cleared BioMarin Pharmaceuticals’s Voxzogo injection for treating achondroplasia, a common form of short-limbed dwarfism in children.
HQ Team October 21, 2023: The USFDA has approved Pfizer Inc.’s vaccine to treat deadly meningococcal disease in young adults between 10 years.
HQ Team October 19, 2023: Experiments conducted on young adult rats have established a link between Alzheimer’s and gut microbiota, according to a.
HQ Team October 18, 2023: Hyloris Pharmaceuticals SA, Liège, Belgium-based biopharma company, announced the US Food and Drug Administration has approved its post-operative.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com